NCT00001763View on ClinicalTrials.gov

Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 1998

Study Completion Date

March 31, 2000

Conditions

Acquired Immunodeficiency SyndromeMycobacterium Avium-Intracellulare Infection

Interventions

DRUG

Interleukin-12

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001763 - Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection | Biotech Hunter | Biotech Hunter